拳头产品大卖超7亿,云顶新耀却因新冠疫苗增亏超3亿,今年将扩充肾病靶向药销售团队

时代财经
27 Mar

为了提升耐赋康的市场覆盖率,罗永庆在上述会议中透露,云顶新耀计划在2025年扩展耐富康销售团队到200人,预计可以覆盖大于80%的市场潜力。图片来源:图虫创意云顶新耀-B(01952.HK)按计划实现销售目标。根据3月26日发布的年度业绩公告,2024年,云顶新耀录得收益7.067亿元,同比增长461%;年内亏损为10.414亿元,上年同期为亏损8.445亿元,同比亏损扩大。根据公告,云顶新耀的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10